Alison McCook | Jun 29, 2009 | 4 min read
Researchers are slowly establishing a connection between an extremely rare genetic disease and HIV -- and homing in on a safe, non-prescription compound that could treat both. Recently, linkurl:James Hildreth;http://www.mmc.edu/faculty/som-jhildreth.html at the Meharry Medical College School of Medicine in Nashville, Tenn., and his colleagues found that cells affected by Niemann-Pick Type C (NPC), which disrupts cholesterol trafficking, were unable to release HIV, suggesting these cells would